Thrombectomy for Acute Ischemic Stroke with Low ASPECTS
Improving Low ASPECTS Stroke Thrombectomy
Recruiting
Observational Study
Acute Ischemic Stroke
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf · Other
Who this trial is looking for
This trial is looking for patients who have had an acute ischemic stroke and need a special kind of treatment. Participants will be treated in stroke centers, and their health information will be collected to help improve future care.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with acute ischemic stroke
- I have an ASPECTS score of 0-5
- I have a confirmed blockage in the carotid artery, middle cerebral artery, or basilar artery
- I am over 18 years old
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
Improving Low ASPECTS Stroke Thromectomy (I-LAST) is an academic, independent, prospective, multicenter, observational registry study. Consecutive patients treated with endovascular stroke treatment will be enrolled in German stroke centers. Patients receive regular care and data will be collected as part of clinical routine. Baseline clinical and procedural information as well clinical follow-up …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Clinical diagnosis of acute ischemic stroke
* ASPECTS of 0-5
* Confirmed diagnosis of persistent occlusion of terminal carotid artery, middle cerebral artery (M1 or M2), or basilar artery consistent with symptoms
* Age \>18 years
* Ethic approval in process
Exclusion Criteria…
Contacts